The IPO also provided the capital to complete Phase … and commercialize DM199 solely for acute ischemic stroke in China, Taiwan, Hong Kong and Macau. Under the terms of the agreement, DiaMedica …
( read original story …)
The Taiwan NEWS
The IPO also provided the capital to complete Phase … and commercialize DM199 solely for acute ischemic stroke in China, Taiwan, Hong Kong and Macau. Under the terms of the agreement, DiaMedica …
( read original story …)